Rhythm Pharmaceuticals (RYTM) Current Deferred Revenue (2021 - 2026)
Rhythm Pharmaceuticals' Current Deferred Revenue was $48,000 in Q1 2026, down 75.3% from the prior quarter.
Analysis
Rhythm Pharmaceuticals (RYTM) Current Deferred Revenue (2021 - 2026) Analysis & Trends
At the end of FY2025, Current Deferred Revenue at Rhythm Pharmaceuticals came in at $194,000, down 84.9% from FY2024.
- Current Deferred Revenue shows a four-year compound annual growth rate of -59.2% (FY2021 to FY2025).
- In earlier years, Current Deferred Revenue was $1.29 million in FY2024 (unchanged), $1.29 million in FY2023 (-10.3%), $1.43 million in FY2022 (-79.5%) and $7 million in FY2021.
- The Q1 2026 figure marks the lowest quarterly Current Deferred Revenue in data going back to Q4 2021.
- Across the past five years, year-over-year decline in Current Deferred Revenue ran from 0.0% in Q4 2024 to 84.9% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 5.46 Bn | 62.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 48,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Mar 31, 2022 | 9.44 Mn |
| Dec 31, 2021 | 7.00 Mn |
API Access
Rhythm Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RYTM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();